Market revenue in 2024 | USD 541.8 million |
Market revenue in 2030 | USD 735.9 million |
Growth rate | 5.2% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.63% in 2024. Horizon Databook has segmented the Middle East & Africa infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East & African (MEA) countries such as South Africa, Saudi Arabia, and the UAE are prospering economies. The market in this region is driven by high prevalence of infectious diseases, rise in consumer awareness, and improvements in healthcare infrastructure.
Thus, MEA is mostly an untapped market for infectious diseases molecular diagnostics. Economic development witnessed in emerging markets, such as South Africa, and high unmet healthcare needs are some of the primary growth drivers for this market.
There is high prevalence of communicable & infectious diseases in this region. However, ethical reasons, poor infrastructure, and affordability might hamper growth. Growing healthcare awareness, increasing initiatives undertaken by various NGOs, improved penetration of health insurance policies, and privatization are some of the factors anticipated to fuel regional market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa infectious disease molecular diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account